NASDAQ: COO
Healthcare · Medical - Instruments & Supplies
Market Cap
$13.14B
52w High
$89.83
52w Low
$58.89
P/E
55.69
Volume
9.08M
Outstanding Shares
195.11M
Price vs Fundamentals
The stock fell 5.39% over the last year. Revenue grew 6.09% over the trailing twelve months. Operating margin moved from 19% to 11.77%. Free cash flow declined 11.67% over the trailing twelve months.
The stock has moved lower against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
Operating margin currently stands at 11.77%. A decisive move in revenue — currently up 6.09% — would be the clearest signal to resolve the ambiguity.
Company profile
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
Valuation
Stock splits
Every 1 shares became 4
Every 1 shares became 2
Every 3 shares became 1
Every 10 shares became 11
Profitability & growth
Analyst consensus
15
Buy
8
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Sep 2, 2026
Q3 FY26 · EPS est $1.14 · Revenue est $1.12B
View